Kepatuhan Pengobatan Multi-Drug Therapy (MDT) dan Faktor yang Mempengaruhinya pada Pasien Morbus Hansen di RSUD RAA Soewondo Pati
DOI:
https://doi.org/10.54259/sehatrakyat.v4i4.5938Keywords:
Hansen’s Disease, Leprosy, Multi-Drug Therapy (MDT)Abstract
Hansen’s disease (leprosy) remains a public health problem in Indonesia. Although national elimination was declared in the year 2000, the number of new cases has remained stagnant at around 17,000–20,000 cases per year, and the proportion of Grade 2 Disability (G2D) remains high. Social stigma, delayed diagnosis, and poor adherence to Multi-Drug Therapy (MDT) continue to be major challenges in achieving elimination. This study aims to evaluate MDT adherence based on three Hansen’s disease patients and to analyze the factors influencing it. This research uses a descriptive design with a three-case report approach analyzed from a public health perspective. The variables assessed include MDT adherence, family support, stigma, patient knowledge, and drug adverse effects. Two of the three patients demonstrated high adherence to MDT, while one patient exhibited non-adherence due to a severe drug reaction (dapsone hypersensitivity syndrome). Factors influencing adherence include patient knowledge, drug side effects, family support, and special conditions such as pregnancy. MDT adherence remains a challenge in leprosy elimination efforts. A multidisciplinary approach involving education, intensive monitoring, and stigma prevention is needed to improve treatment success.
Downloads
References
Claudio G, Arival C, Ubirajara I, John S. Leprosy. In: Fitzpatrick TB, Goldsmith LA, Wolff K, editors. Fitzpatrick’s Dermatology. 9th ed. New York: McGraw-Hill; 2019.
Menaldi SL, SW. Buku Ilmu Penyakit Kulit dan Kelamin. Edisi ketujuh. Jakarta: Balai Penerbit FK UI; 2019.
Kementerian Kesehatan Republik Indonesia. Peraturan Menteri Kesehatan Republik Indonesia Nomor 11 Tahun 2019 Tentang Penanggulangan Kusta.
Sandra W, Hardyanto S, Hanny N, dkk. Panduan Praktik Klinis Bagi Dokter Spesialis Kulit dan Kelamin di Indonesia. Jakarta: PP Perdoski; 2017.
Djuanda A. Buku Ajar Ilmu Penyakit Kulit dan Kelamin. Edisi ketujuh. DKI Jakarta, Depok: Fakultas Kedokteran Universitas Indonesia; 2019.
Hess et al., Cell Biology of Intracellular Adaptation of Mycobacterium leprae in the Peripheral Nervous System, Microbiology Spectrum, 2019.
Pertiwi ANA, Syahrul F. Risk Factors for Leprosy: A Systematic Review. The Indonesian Journal of Public Health. 2024;19(3):575-589.
Hasanuddin University, Kegiatan Deteksi Nasal Swab: Molecular Identification of Mycobacterium leprae in Nasal Swab Specimens among Pretreatment, On-treatment, and Post-treatment Leprosy Patients in Bulukumba, South Sulawesi, Indonesia. International Journal of Mycobacteriology. 2024;13(3):288-292.
Dharmawan Y, Korfage IJ, Abqari U, et al. Measuring leprosy case detection delay and associated factors in Indonesia: a community-based study. BMC Infectious Diseases. 2023;23:555.
Reza Agustiantwo Putra. The Role of Innate Immunity against Mycobacterium Leprae: A Systematic Literature Review. Scientific Journal of Dermatology and Venereology. 2024;2(1):31-37
Mukti B, Ivantirta I, Zuraida R. Penatalaksanaan holistik pasien laki-laki usia 51 tahun dengan Morbus Hansen multibasiler melalui pendekatan dokter keluarga. Jurnal Penelitian Perawat Profesional. 2024;6(5):1927–40. doi:10.37287/jppp.v6i5.3117.
Siregar RS. Atlas Berwarna Saripati Penyakit Kulit. Edisi ke-3. Jakarta: EGC; 2015.
Sobero HT. Diagnosis dan penatalaksanaan kusta. Medula: FK Universitas Lampung. 2021.
Rachmawati WC. Promosi Kesehatan dan Ilmu Perilaku. Malang: Wineka Media; 2019.
Price SA, Wilson LM. Patofisiologi: Konsep Klinis Proses-Proses Penyakit. Edisi ke-6. Jakarta: EGC; 2012.
World Health Organization (WHO). Global leprosy (Hansen disease) update, 2019: time to step-up prevention initiatives. Wkly Epidemiol Rec. 2020;95(36):417–40.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Elly Mazida, Erna Kristiyani, Shirly Gunawan

This work is licensed under a Creative Commons Attribution 4.0 International License.
Hak cipta pada setiap artikel adalah milik penulis.
Penulis mengakui bahwa SEHATRAKYAT (Jurnal Kesehatan Masyarakat) sebagai publisher yang mempublikasikan pertama kali dengan lisensi Creative Commons Attribution 4.0 International License.
Penulis dapat memasukan tulisan secara terpisah, mengatur distribusi non-ekskulif dari naskah yang telah terbit di jurnal ini kedalam versi yang lain, seperti: dikirim ke respository institusi penulis, publikasi kedalam buku, dan lain-lain. Dengan mengakui bahwa naskah telah terbit pertama kali pada SEHATRAKYAT (Jurnal Kesehatan Masyarakat).





















